|
CN105030952A
|
|
Composition for preventing urinary stone
|
|
CN104997880A
|
|
Urinary calculus prevention composition
|
|
CN104739825A
|
|
Application of isoalantolactone in preparation of medicines for resisting chronic myeloid leukemia
|
|
CN104490868A
|
|
Application of atractylenolide-II derivative in preparation of platelet aggregation resisting drug and platelet aggregation resisting drug
|
|
CN104490869A
|
|
Application of atractylenolide-III derivative in preparation of platelet aggregation resisting drug and platelet aggregation resisting drug
|
|
CN103360385A
|
|
Compound and medicament for treating MRSA (Methicillin-resistant Staphylococcus Aureus) infection
|
|
CN102921090A
|
|
Development catheter applied to treatment of chronic total occlusion
|
|
CN103239763A
|
|
Sutureless ureterostenosis restoration operation material and system thereof
|
|
CN102534012A
|
|
Nucleic acid marker for gel electrophoresis as well as preparation method and application thereof
|
|
CN103170072A
|
|
Fire protection transferring simple respirator
|
|
CN103083367A
|
|
Losartan ginkgo leaf compound preparation and preparation method thereof
|
|
CN102952848A
|
|
Detection method of small non-messenger RNA
|
|
CN102652763A
|
|
Traditional Chinese medicine preparation for treating burn and scald and preparation method thereof
|
|
CN102652837A
|
|
Medicament for treating colorectal cancer
|
|
CN102125546A
|
|
Composition for preventing renal calculi
|
|
CN102462694A
|
|
Application of hydrogen to preparation of medicament and health-care beverage for preventing kidney stones
|
|
CN102204848A
|
|
Medical restraint strap
|
|
CN101990858A
|
|
Device for generating diffuse axonal injury to rodent
|
